Michael Sinha
@drsinhaesq.bsky.social
MD JD MPH FCLM FAMWA • Associate Prof @SLUHealthLaw.bsky.social @SLULAW.bsky.social • Former #NUSLHealth @PORTALResearch.org #HarvardMIT_CRS #HeForShe • 🇮🇸 🇮🇳 🇺🇸
NEW: FDA symposium issue is out from Utah Law Review @sjquinney.bsky.social. Open access. Thx to amazing scholars who came to symposium & wrote for the issue including @saragerke.bsky.social @pzettler.bsky.social @rachelsachs.bsky.social @drsinhaesq.bsky.social dc.law.utah.edu/ulr/
Utah Law Review | SJ Quinney College of Law, University of Utah
dc.law.utah.edu
We're hiring in health law! Spread the word, northeastern.wd1.myworkdayjobs.com/careers/job/...
Assistant Professor/Associate Professor/Professor (Open Rank), School of Law – Health Policy and Law
About the Opportunity Northeastern University School of Law is seeking candidates at all ranks for full-time tenured or tenure-track faculty positions to join our scholarly community and enhance our l...
northeastern.wd1.myworkdayjobs.com
Accompanying post in the @petrieflomcenter.bsky.social Bill of Health Blog A Path to Stability at @fda.gov? petrieflom.law.harvard.edu/2026/09/14/a...
A Path to Stability at FDA? - Petrie-Flom Center
In September 2025 at the University of Utah S.J. Quinney College of Law, I presented a paper titled “FDA in 2050: Best- and Worst-Case Scenarios,” which was recently published in the Utah Law Review.
petrieflom.law.harvard.edu
Michael Sinha@drsinhaesq.bsky.social · last wk.Now published in the Utah Law Review: dc.law.utah.edu/ulr/vol2026/... Based on my presentation at the fall 2025 Lee E. Teitelbaum Utah Law Review Symposium at @sjquinney.bsky.social -- Fireproofing the @fda.gov: Power, Politics, and Public Health (organized by @medlawdan.bsky.social)
Now published in the Utah Law Review: dc.law.utah.edu/ulr/vol2026/... Based on my presentation at the fall 2025 Lee E. Teitelbaum Utah Law Review Symposium at @sjquinney.bsky.social -- Fireproofing the @fda.gov: Power, Politics, and Public Health (organized by @medlawdan.bsky.social)
FDA in 2050: Best- and Worst-Case Scenarios
In 2025, the Trump administration disrupted many critical aspects of the biomedical research infrastructure in the United States. The Food and Drug Administration (FDA) was not spared. Robert F. Kenne...
dc.law.utah.edu
Just heard some sad news: Peter Barton Hutt has passed away. I think it’s fair to say he was the most important food and drug lawyer in the country. In January, every year, he’d teach a wonderful course at my school. I wrote a long essay on cheese regulation for him. RIP www.peterbartonhutt.com
Peter Barton Hutt
peterbartonhutt.com
Leaders of Rx4J, SLU's MLP, submitted comments to HHS on its Medicaid work requirements interim final rule, raising concerns re: provisions that could lead to coverage losses & create barriers to protections intended by Congress. Full letter: www.slu.edu/law/health/-... @pelfreyduryea.bsky.social
slu.edu
Officially published in @emorylaw.bsky.social ECGAR (now the Emory Business Law Review): Pharmaceutical-Telehealth Confederacies (with Michelle Onder, JD, MPH, @slulaw.bsky.social '25) scholarlycommons.law.emory.edu/ecgar/vol13/... @sluhealthlaw.bsky.social
Pharmaceutical-Telehealth Confederacies
Access to prescription pharmaceuticals has historically been controlled by a physician’s pen. As a result, pharmaceutical companies spend billions of dollars on advertising and promotion to mitigate t...
scholarlycommons.law.emory.edu
Perspective by T.N. Anderson et al.: Ambient AI in Clinical Practice — The Legal Landscape of Recording Consent Requirements https://nej.md/43esKuR #ArtificialIntelligence #AIinMedicine
Excellent updates and Q&A on the past year at the FDA and thoughts about what comes next with Michael Sinha, Patti Zettler, Erika Lietzan, Nathan Cortez, and Lewis Grossman. @drsinhaesq.bsky.social @pzettler.bsky.social @nathancortez.bsky.social
Day 3 of #hlp26! First, Michael Sinha on the future of the FDA & Molly Wilson on the politicization of repro care. Later, Danielle Pelfrey Duryea on educating residents and student-attorneys & Sidney Watson discusses the future of Medicaid. @pelfreyduryea.bsky.social @drsinhaesq.bsky.social
Join us in congratulating our 2026 class of Health Law Scholars! ⭐️ Ximena Benavides Reverditto @drximebena.bsky.social ⭐️ Alexander Chen ⭐️ Yaron Covo ⭐️ Amy Saji @amysaji.bsky.social
Ambient AI documentation tools carry legal risks around consent, data transmission, and state recording laws. A new Perspective outlines strategies to mitigate liability and support transparent implementation. https://nej.md/43esKuR #ArtificialIntelligence #AIinMedicine
#HLPC26 #HLP26 ASLME @jlme-journal.bsky.social "6B: Turbulence at @fda.gov: The Year in Review and Predicting the Future" Looking forward to joining Lewis Grossman, @pzettler.bsky.social, Erika Lietzan & @nathancortez.bsky.social for this important discussion!
Find us at the #HealthLaw Professors Conference in Atlanta next week! @kellygillespie.bsky.social @drsinhaesq.bsky.social @amynsanders.bsky.social @robgatter.bsky.social @pelfreyduryea.bsky.social @profwaltermac.bsky.social @jlme-journal.bsky.social @slu-official.bsky.social #hlpc2026
Just in time for our ASLME #HLPC26 panel in a few weeks, titled "What's in the Crystal Ball? Predicting the Future of the FDA"
Dan Diamond@ddiamond.bsky.social · 5mo agoThe Marty Makary era is ending at FDA. Commissioner plans to resign today, people tell @rachelroubein.bsky.social and me, confirming Politico.
Grateful & very excited to welcome Nicole Tuchinda, JD, MD, LLM to SLU Law! Her expertise in health justice, childhood trauma, and equity will strengthen our community and increase our impact. Read more: www.slu.edu/law/news/202... @slulaw.bsky.social @slu-official.bsky.social
School of Law Adds Nicole Tuchinda to the Center for Health Law Studies Faculty
Saint Louis University School of Law is pleased to announce the appointment of child health justice advocate, Nicole Tuchinda, J.D., M.D., LL.M. to the faculty beginning in July 2026. Dr. Tuchinda’s a...
slu.edu
SLU Honors Scholarly Works and Grant Winners: www.slu.edu/news/announc... @slu-official.bsky.social @slulaw.bsky.social @sluhealthlaw.bsky.social
My @jama.com article with Sean Tu, Dave Slade, and Timothy Bonis was recognized this week with a 2026 @slu-official.bsky.social Scholarly Works award in the Senior Faculty, Clinical Articles category! Article here: jamanetwork.com/journals/jam...
Presenting with @slulaw.bsky.social @sluhealthlaw.bsky.social colleague Heather McCabe later today on "Current Developments in Public Health Law: Impact on Missouri"
Heather McCabe@profwaltermac.bsky.social · 2y agoI am a passionate advocate for LGBTQ Health Equity at SLU Law in the Center for Health Law Studies. I am a JD/MSW working at the intersection of law, public health, & social work. 🌈🎓
Ended the semester in Patent Law at @slulaw.bsky.social with two terrific guest lectures! Prof. Sean Tu presented "Expanding Patent Portfolios and Delayed Competition for Brand-Name Drugs" Prof. Jordana Goodman presented "Patently Inequitable"
The final hours for 2026 Health Law Scholars applications are upon us. Don't miss out on your chance to submit an abstract for consideration! More information on the submission process and workshop weekend is available on our website: www.slu.edu/law/health/s...
Health Law Scholars Workshop
New faculty in the fields of health law and bioethics are invited to present scholarship for review in this collegial forum.
slu.edu
SLU Law Center for Health Law Studies@sluhealthlaw.bsky.social · 6mo agoLast call for submissions to the 2026 ASLME & SLU Law Health Law Scholars Workshop. Abstracts due by Monday, April 13! More info on the program & how to submit available here: www.slu.edu/law/health/s... @slu-official.bsky.social @slulaw.bsky.social @jlme-journal.bsky.social
Always a pleasure to speak to the graduating M4s at Saint Louis University School of Medicine as part of their capstone course! My talk was titled "Pharmaceutical Prescribing: Pearls and Pitfalls." #MedEd cc: @sluhealthlaw.bsky.social
A tradition like no other: for 32 years, my @slulaw.bsky.social colleague Prof. Thomas Stewart has welcomed the entire 4th year SLU School of Medicine class to our courtroom to observe a mock trial, introducing them to the nuances of medical malpractice.
Recap and 📽️📼📺: @sluhealthlaw.bsky.social 38th Annual Health Law Symposium -- A Defining Moment for Vaccine Science and Policy t.e2ma.net/share/inboun...
Recap: SLU Law's 38th Annual Health Law Symposium -- A Defining Moment for Vaccine Science and Policy
SLU LAW Center for Health Law Studies 100 N. Tucker Blvd. /// St. Louis, MO 63101 HealthLaw@slu.edu (mailto:HealthLaw@slu.edu) A Defining Moment for Vaccine Science and Policy 38th Annual Health Law S...
t.e2ma.net
SLU Law Center for Health Law Studies @sluhealthlaw.bsky.social Celebrates First in the Nation Ranking in Health Care Law www.slu.edu/law/news/202...
Center for Health Law Studies Celebrates First in the Nation Ranking in Health Care Law
The Center for Health Law Studies was recognized as the number one program for the 2027 US News and World Report health care law rankings.
slu.edu
Thanks to @doritreiss.bsky.social for live posting @nusl.bsky.social #HLC2026, and in particular, our FDA panel!
Dorit Reiss@doritreiss.bsky.social · 6mo agoSays @drsinhaesq.bsky.social in the panel on the FDA regulatory environment in #HLC2026 in @NUSL: over decades there were great scientists with institutional knowledge and expertise. When Makary appointed 3000 fired - position to make appointments, and they were political.
Glad to join @sbagen.bsky.social and @drsinhaesq.bsky.social on this panel at @nusl.bsky.social's annual health law conference, with very thoughtful moderation from @davidasimon.bsky.social. Thanks to @doritreiss.bsky.social for liveposting!
Dorit Reiss@doritreiss.bsky.social · 6mo agoSays @rachelsachs.bsky.social in the panel on the FDA regulatory environment in #HLC2026 in @NUSL: because drug development path is long, important that companies can trust that advice they get at point A will hold. High turnout - companies reporting - advice from FDA changing, moving goal posts.
This was a ton of fun. (And don't worry -- I really don't care how people pronounce my name!)
David A. Simon@davidasimon.bsky.social · 6mo agoGreat time moderating a panel in the FDA with @sbagen.bsky.social, @rachelsachs.bsky.social, and @drsinhaesq.bsky.social at @nusl.bsky.social annual health law conference. As usual, I butchered at least one name (Sam’s)
